NEW YORK (GenomeWeb News) – A bill to create a national institute to study comparative clinical effectiveness of medical treatments and diagnostics — including the use of molecular medicine and genetics to inform those studies — was introduced in the US Senate this week by Senators Max Baucus (D – Mont.) and Kent Conrad (D – ND).

The bill calls for the creation of the Patient-Centered Outcomes Research Institute, which would be a non-profit entity run by "a multi-stakeholder, public-private sector board of governors," Baucus said in a floor statement to the Senate on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.